Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1349834생성일: 2026년 10월 26일
Piracetam hydrazide → 1-({3-[3-(4-Fluorophenyl)-1H-Indazol-5-Yl]-1H-1,2,4-Triazol-5-Yl}Methyl)Pyrrolidine-2-One
https://huagongshe.com/reaction/1349834
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Piracetam hydrazide | HCID 3565593 | — |
| 반응물 | Sodium Methoxide | HCID 10942334 | — |
| 반응물 | ethoxy[3-(4fluorophenyl)(1H-indazol-5-yl)]methanimine hydrochloride | HCID 22479739 | — |
| 용매 | Methanol | HCID 887 | — |
| 생성물 | 1-({3-[3-(4-Fluorophenyl)-1H-Indazol-5-Yl]-1H-1,2,4-Triazol-5-Yl}Methyl)Pyrrolidine-2-One | HCID 22480256 | 34% |
반응 단계
A suspension of ethoxy[3-(4-fluorophenyl)(1H-indazol-5-yl)]methanimine hydrochloride (0.300 g, 0.94 mmol) and N-amino-2-(2-oxopyrrolidinyl)acetamide (0.442 g, 2.81 mmol) in 4 mL of anhydrous methanol was prepared. An excess of a commercial solution of sodium methoxide in methanol (0.643 mL, 4.37 M) was added. Upon adding the basic solution, the reaction mixture became clear then cloudy. After an hour, the temperature was raised to reflux temperature and was maintained for 48 hours. The reaction was then quenched with water, the pH adjusted to neutral and the crude product extracted with ethyl acetate. The title compound was purified by preparative HPLC (0.118 g, 34% yield): 1H NMR (CD3OD) δ 8.68 (s, 1H), 8.07–8.02 (m, 3H), 7.68 (d, 1H), 7.29 (t, 2H), 4.66 (s, 2H), 3.53 (t, 2H), 2.47 (t, 2H), 2.10 (quintet, 2H); ES-MS (m/z) 377 [M+H]+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07211594B2 |
|---|
| 출처 데이터셋 | uspto-grants-2007_05 |
|---|
| ORD ID | ord-b09a52db5b314b319dd4f21770f7d0f3 |
|---|
| 출처 메모 | uspto-grants-2007_05 |
|---|